The Cancer Targeted Therapy Market size is expected to reach US$ 235.68 Billion by 2031 from US$ 95.12 Billion in 2024. The market is estimated to record a CAGR of 13.84% from 2025 to 2031. The increasing global burden of cancer, rapid advancements in precision medicine, and growing demand for personalized treatment approaches are significantly driving the growth of the global cancer targeted...

The Cancer Targeted Therapy Market size is expected to reach US$ 235.68 Billion by 2031 from US$ 95.12 Billion in 2024. The market is estimated to record a CAGR of 13.84% from 2025 to 2031. The increasing global burden of cancer, rapid advancements in precision medicine, and growing demand for personalized treatment approaches are significantly driving the growth of the global cancer targeted...

The South and Central America Cancer Targeted Therapy Market is expanding as healthcare systems increasingly adopt precision-based cancer treatment and advanced oncology solutions. The South and Central America Cancer Targeted Therapy Market size is expected to reach US$ 10,151.9 million by 2031 from US$ 4,725.4 million in 2024. The market is estimated to record a CAGR of 11.6% from 2025 to...

The Middle East Cancer Targeted Therapy Market is expanding as healthcare systems increasingly adopt precision-based approaches to cancer treatment. The Middle East Cancer Targeted Therapy Market size is expected to reach US$ 2,163.7 million by 2031 from US$ 1,051.4 million in 2024. The market is estimated to record a CAGR of 10.9% from 2025 to 2031. Cancer targeted therapy is becoming an...